NCR3 and cancer: In this context, the data from our and other groups have reported that the co-stimulatory molecule B7-H6 was over-expressed on cancer cells and binds to its receptor NKp30 on the NK cells, and thus leads to negative regulation of NK cells, which in-turn promotes cancer progression [25–29].